Growth Metrics

AbCellera Biologics (ABCL) Shares Issued (2020 - 2024)

AbCellera Biologics' Shares Issued history spans 4 years, with the latest figure at $227000.0 for Q3 2024.

  • For the quarter ending Q3 2024, Shares Issued fell 11.33% year-over-year to $227000.0, compared with a TTM value of $1.8 million through Sep 2024, down 36.99%, and an annual FY2021 reading of $4.6 million, down 99.12% over the prior year.
  • Shares Issued for Q3 2024 was $227000.0 at AbCellera Biologics, down from $461000.0 in the prior quarter.
  • The five-year high for Shares Issued was $521.9 million in Q4 2020, with the low at $124000.0 in Q1 2020.
  • Average Shares Issued over 4 years is $37.9 million, with a median of $475500.0 recorded in 2023.
  • Biggest YoY gain for Shares Issued was 1246.46% in 2021; the steepest drop was 99.65% in 2021.
  • Tracing ABCL's Shares Issued over 4 years: stood at $521.9 million in 2020, then crashed by 99.65% to $1.8 million in 2021, then crashed by 86.04% to $256000.0 in 2023, then dropped by 11.33% to $227000.0 in 2024.
  • Per Business Quant, the three most recent readings for ABCL's Shares Issued are $227000.0 (Q3 2024), $461000.0 (Q2 2024), and $892000.0 (Q1 2024).